OK here is my take. Let's see what the market thinks at 10.00am
Operating cash outflow reduced from $23.4m to $13.4m
EBITDA (excluding non cash share based payments) down to $18.5m from $27.4m
Significant margin improvement when duplicate platform costs drop off once transition to AWS is complete
Margin also affected by AWS transition which has required investment(one off)
At $303m revenue for next financial year, xero would actually be break even. So if they did not add one subscriber and kept costs same as last FY, break even would occur
Cash balance still 140m
Business reaffirmed not expected to raise capital again
New goal seems to be $1b revenue not 1m customers
UK market , xero has number one product, and still < 5% market. In years to come I can see it maturing to a NZ market and 30% will be around 700-800k customers
AWS integration will allow xero to attract larger customers at a premium subscription rate
Early adoption in SA and Asia looks promising
Australia still only 15% of market. This can double in next few years as most businesses transition to cloud
Pretty impressive outlook
- Forums
- ASX - By Stock
- XRO
- My analysis
XRO
xero limited
Add to My Watchlist
0.86%
!
$178.01

My analysis
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$178.01 |
Change
1.510(0.86%) |
Mkt cap ! $29.30B |
Open | High | Low | Value | Volume |
$177.24 | $180.00 | $177.20 | $76.62M | 429.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 58 | $177.92 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$178.04 | 26073 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 85 | 177.500 |
2 | 61 | 177.400 |
1 | 141 | 177.300 |
3 | 178 | 177.000 |
2 | 250 | 176.750 |
Price($) | Vol. | No. |
---|---|---|
178.500 | 100 | 1 |
179.870 | 50 | 1 |
179.990 | 280 | 1 |
180.000 | 888 | 5 |
180.090 | 500 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
XRO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online